M
M. Joanne Lemieux
Researcher at University of Alberta
Publications - 82
Citations - 3663
M. Joanne Lemieux is an academic researcher from University of Alberta. The author has contributed to research in topics: Rhomboid protease & Protease. The author has an hindex of 24, co-authored 76 publications receiving 2845 citations. Previous affiliations of M. Joanne Lemieux include New York University.
Papers
More filters
Journal ArticleDOI
Structure and Mechanism of the Glycerol-3-Phosphate Transporter from Escherichia Coli
TL;DR: This work reports the 3.3 angstrom resolution structure of a member of the major facilitator superfamily, GlpT, which transports glycerol-3-phosphate into the cytoplasm and inorganic phosphate into the periplasm and proposes that it operates by a single–binding site, alternating-access mechanism through a rocker-switch type of movement.
Journal ArticleDOI
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.
Wayne Vuong,Muhammad Bashir Khan,Conrad Fischer,Elena Arutyunova,Tess Lamer,Justin Shields,Holly A. Saffran,Ryan T. McKay,Marco J. van Belkum,Michael A. Joyce,Howard S. Young,D. Lorne Tyrrell,John C. Vederas,M. Joanne Lemieux +13 more
TL;DR: The main protease, Mpro (or 3CLpro) in SARS-CoV-2 is a viable drug target because of its essential role in the cleavage of the virus polypeptide and NMR analysis reveals that inhibition proceeds via reversible formation of a hemithioacetal.
Journal ArticleDOI
Crystallographic Structure of Human β-Hexosaminidase A: Interpretation of Tay-Sachs Mutations and Loss of GM2 Ganglioside Hydrolysis
M. Joanne Lemieux,Brian L. Mark,Maia M. Cherney,Stephen G. Withers,Don J. Mahuran,Michael N.G. James +5 more
TL;DR: NGT, a mechanism-based inhibitor, has been shown to act as a chemical chaperone that prevents misfolding of a Hex A mutant associated with adult onset Tay Sachs disease and, as a result, increases the residual activity of Hex A to a level above the critical threshold for disease.
Journal ArticleDOI
The crystal structure of the rhomboid peptidase from Haemophilus influenzae provides insight into intramembrane proteolysis.
TL;DR: The structural results on these rhomboid peptidases have allowed us to speculate on the catalytic mechanism of substrate cleavage in a membranous environment and to identify the relative disposition of the nucleophilic serine to the general base/acid function of the conserved histidine.
Posted ContentDOI
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
Wayne Vuong,Muhammad Bashir Khan,Conrad Fischer,Elena Arutyunova,Tess Lamer,Justin Shields,Holly A. Saffran,Ryan T. McKay,Marco J. van Belkum,Michael A. Joyce,Howard S. Young,D. Lorne Tyrrell,John C. Vederas,M. Joanne Lemieux +13 more
TL;DR: GC373 and GC376 are potent inhibitors of SARS-CoV-2 in cell culture, with EC50 values near one micromolar and little to no toxicity and the framework for their use in human trials for the treatment of COVID-19 is laid.